We are live on ! Find out more
QCG

Quadrant Capital Group Portfolio holdings

AUM $3.34B
1-Year Est. Return 29.16%
This Fund
S&P 500
This Quarter Est. Return
-0.75%
1 Year Est. Return
+29.16%
3 Year Est. Return
+77.72%
5 Year Est. Return
+92.59%
10 Year Est. Return
+303.92%
AUM
$276M
AUM Growth
+$24.9M
Cap. Flow
+$30.6M
Cap. Flow %
11.11%
Top 10 Hldgs %
20.76%
Holding
2,326
New
130
Increased
835
Reduced
304
Closed
60

Top Buys

Rank Stock Value
1
TGT icon
Target
TGT
+$9.21M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$1.76M
3
KMB icon
Kimberly-Clark
KMB
+$1.7M
4
VNQ icon
Vanguard Real Estate ETF
VNQ
+$1.5M
5
AAPL icon
Apple
AAPL
+$1.26M

Sector Composition

Rank Sector Weight
1 Financials 11.06%
2 Technology 10.02%
3 Consumer Staples 9.8%
4 Healthcare 7.77%
5 Industrials 6.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRSN icon
251
VeriSign
VRSN
$25.3B
$165K 0.06%
1,428
+15
+1% +$1.74K
BNY
252
Bank of New York Mellon
BNY
$108B
$164K 0.06%
3,320
-14
-0.4% -$779
AGN
253
DELISTED
Allergan plc
AGN
$164K 0.06%
1,020
+46
+5% +$7.72K
CNQ icon
254
Canadian Natural Resources
CNQ
$96.9B
$163K 0.06%
11,249
+337
+3% +$5.42K
COP icon
255
ConocoPhillips
COP
$147B
$163K 0.06%
3,029
+19
+0.6% +$1.07K
TEF
256
DELISTED
Telefonica
TEF
$163K 0.06%
21,391
-1,288
-6% -$10.2K
STZ icon
257
Constellation Brands
STZ
$22.2B
$162K 0.06%
774
+27
+4% +$5.95K
NXPI icon
258
NXP Semiconductors
NXPI
$68B
$161K 0.06%
1,441
BSX icon
259
Boston Scientific
BSX
$65.8B
$158K 0.06%
6,119
+1,035
+20% +$28.1K
GSK icon
260
GSK
GSK
$103B
$158K 0.06%
3,494
+1,628
+87% +$75.8K
DRE
261
DELISTED
Duke Realty Corp.
DRE
$157K 0.06%
6,264
+25
+0.4% +$643
AVNS icon
262
Avanos Medical
AVNS
$1.17B
$154K 0.06%
3,393
+1,924
+131% +$91.3K
CHKP icon
263
Check Point Software Technologies
CHKP
$13.3B
$154K 0.06%
1,610
+278
+21% +$28.6K
HIT
264
DELISTED
HITACHI LTD ADR (10COM)NEW
HIT
$154K 0.06%
2,268
ADBE icon
265
Adobe
ADBE
$89.5B
$150K 0.05%
746
+41
+6% +$8.34K
EW icon
266
Edwards Lifesciences
EW
$47.6B
$150K 0.05%
3,408
+30
+0.9% +$1.3K
MDT icon
267
Medtronic
MDT
$107B
$150K 0.05%
2,013
+298
+17% +$24.6K
ES icon
268
Eversource Energy
ES
$28.2B
$147K 0.05%
2,691
+31
+1% +$1.83K
ASML icon
269
ASML
ASML
$675B
$146K 0.05%
801
CLX icon
270
Clorox
CLX
$11.6B
$146K 0.05%
1,193
+370
+45% +$49.7K
STLA icon
271
Stellantis
STLA
$16.5B
$144K 0.05%
7,189
BABA icon
272
Alibaba
BABA
$269B
$143K 0.05%
796
+34
+4% +$6.4K
WAT icon
273
Waters Corp
WAT
$36.8B
$143K 0.05%
758
KUB
274
DELISTED
KUBOTA CORPORATION (ONE ADS REP 5 SHS COM)
KUB
$143K 0.05%
1,740
+192
+12% +$15.8K
COF icon
275
Capital One
COF
$124B
$142K 0.05%
1,625
+53
+3% +$5.28K

Similar funds

Quadrant Capital Group's Q1 2018 Portfolio in Review

As of Q1 2018, Quadrant Capital Group held 2,326 positions worth $276M, up 9.9% from $251M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Quadrant Capital Group deployed $30.6M of net new capital in Q1 2018, opening 130 new positions and adding to 835 existing holdings. Its largest new stake was Schwab Fundamental US Large Company Index ETF: 34,440 shares worth $417K.

By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 12% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was Meridian Bioscience Inc, an estimated $2.34M trimmed.

  • Quadrant Capital Group's largest Q1 2018 buy was Schwab Fundamental US Large Company Index ETF: 34,440 shares worth $417K.
  • Quadrant Capital Group added most to Target in Q1 2018, an estimated $9.21M increase.
  • Quadrant Capital Group's biggest Q1 2018 reduction was Meridian Bioscience Inc, cutting an estimated $2.34M.
  • Quadrant Capital Group fully exited CNH Industrial in Q1 2018, selling an estimated $130K.
  • Quadrant Capital Group's ten largest holdings make up 21% of its $276M portfolio in Q1 2018.
  • Quadrant Capital Group opened 130 new positions and closed 60 in Q1 2018.
  • Quadrant Capital Group's portfolio value rose 9.9% quarter-over-quarter to $276M.

Based on Quadrant Capital Group's 13F filing for Q1 2018, filed 10 May 2018.